HIV-1 protease: mechanism and drug discovery
作者： Ashraf Brik , Chi-Huey Wong
DOI: 10.1039/B208248A
关键词:
摘要: … We have described a new pyrrolidine α-keto amide core structure as a mechanism-based inhibitor for HIV PR. The crystal structure shows that this inhibitor is bound to HIV PR in its …
rsc.org
sci-hub.se 参考文章(39)
William J. Greenlee, Peter K.S. Siegl, Chapter 7. Anglotensln / Renln Modulators Annual Reports in Medicinal Chemistry. ,vol. 27, pp. 59- 68 ,(1992) , 10.1016/S0065-7743(08)60405-4
Thomas D. Meek, Evelyn J. Rodriguez, Thelma S. Angeles, Use of steady state kinetic methods to elucidate the kinetic and chemical mechanisms of retroviral proteases. Methods in Enzymology. ,vol. 241, pp. 127- 156 ,(1994) , 10.1016/0076-6879(94)41063-1
P L Darke, C T Leu, L J Davis, J C Heimbach, R E Diehl, W S Hill, R A Dixon, I S Sigal, Human immunodeficiency virus protease. Bacterial expression and characterization of the purified aspartic protease. Journal of Biological Chemistry. ,vol. 264, pp. 2307- 2312 ,(1989) , 10.1016/S0021-9258(18)94177-3
Toshimasa Yamazaki, Linda K. Nicholson, Paul Wingfield, Stephen J. Stahl, Joshua D. Kaufman, Charles J. Eyermann, C. Nicholas Hodge, Patrick Y. S. Lam, D. A. Torchia, NMR and X-ray Evidence That the HIV Protease Catalytic Aspartyl Groups Are Protonated in the Complex Formed by the Protease and a Non-Peptide Cyclic Urea-Based Inhibitor Journal of the American Chemical Society. ,vol. 116, pp. 10791- 10792 ,(1994) , 10.1021/JA00102A057
Mariusz Jaskolski, Alfredo G. Tomasselli, Tomi K. Sawyer, Douglas G. Staples, Robert L. Heinrikson, Jens Schneider, Stephen B. H. Kent, Alexander Wlodawer, Structure at 2.5-A resolution of chemically synthesized human immunodeficiency virus type 1 protease complexed with a hydroxyethylene-based inhibitor. Biochemistry. ,vol. 30, pp. 1600- 1609 ,(1991) , 10.1021/BI00220A023
Noel A Roberts, Joseph A Martin, Derek Kinchington, Anne V Broadhurst, J Charles Craig, Ian B Duncan, Sarah A Galpin, Balraj K Handa, John Kay, Antonin Kröhn, Robert W Lambert, John H Merrett, John S Mills, Kevin EB Parkes, Sally Redshaw, Alison J Ritchie, Debra L Taylor, Gareth J Thomas, Peter J Machin, Rational design of peptide-based HIV proteinase inhibitors Science. ,vol. 248, pp. 358- 361 ,(1990) , 10.1126/SCIENCE.2183354
R. Bott, E. Subramanian, D. R. Davies, Three-dimensional structure of the complex of the Rhizopus chinensis carboxyl proteinase and pepstatin at 2.5 .ANG. resolution Biochemistry. ,vol. 21, pp. 6956- 6962 ,(1982) , 10.1021/BI00269A052
Robert C. Gallo, Luc Montagnier, AIDS in 1988. Scientific American. ,vol. 259, pp. 40- 48 ,(1988) , 10.1038/SCIENTIFICAMERICAN1088-40
Patrick YS Lam, Prabhakar K Jadhav, Charles J Eyermann, C Nicholas Hodge, Yu Ru, Lee T Bacheler, James L Meek, Michael J Otto, Marlene M Rayner, Y Nancy Wong, Chong-Hwan Chang, Patricia C Weber, David A Jackson, Thomas R Sharpe, Susan Erickson-Viitanen, Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors Science. ,vol. 263, pp. 380- 384 ,(1994) , 10.1126/SCIENCE.8278812
Stefano Piana, Daniel Sebastiani, Paolo Carloni, Michele Parrinello, Ab initio molecular dynamics-based assignment of the protonation state of pepstatin A/HIV-1 protease cleavage site. Journal of the American Chemical Society. ,vol. 123, pp. 8730- 8737 ,(2001) , 10.1021/JA003145E